NDC 84165-109
This exact product or package identity exists in FDA auxiliary data but is not present in the current primary NDC product table. The package identity is preserved; status rows are reported source observations, not medical conclusions.
- Requested NDC
- 84165-109
- Product root
- 84165-109
- Identity scope
- Product
- Primary current NDC product row
- Not present
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 84165-109 | D | Discontinued by firm | 2026-10-05 | ||
| excluded package | package | 84165-109 | 84165-109-01 | D | Discontinued by firm | 2026-10-05 | |
| excluded package | package | 84165-109 | 84165-109-04 | D | Discontinued by firm | 2026-10-05 | |
| excluded package | package | 84165-109 | 84165-109-06 | D | Discontinued by firm | 2026-10-05 | |
| excluded package | package | 84165-109 | 84165-109-08 | D | Discontinued by firm | 2026-10-05 | |
| excluded package | package | 84165-109 | 84165-109-10 | D | Discontinued by firm | 2026-10-05 | |
| excluded package | package | 84165-109 | 84165-109-12 | D | Discontinued by firm | 2026-10-05 | |
| excluded package | package | 84165-109 | 84165-109-13 | D | Discontinued by firm | 2026-10-05 | |
| excluded package | package | 84165-109 | 84165-109-18 | D | Discontinued by firm | 2026-10-05 | |
| excluded package | package | 84165-109 | 84165-109-20 | D | Discontinued by firm | 2026-10-05 | |
| excluded package | package | 84165-109 | 84165-109-24 | D | Discontinued by firm | 2026-10-05 | |
| excluded package | package | 84165-109 | 84165-109-30 | D | Discontinued by firm | 2026-10-05 | |
| excluded package | package | 84165-109 | 84165-109-32 | D | Discontinued by firm | 2026-10-05 | |
| excluded package | package | 84165-109 | 84165-109-36 | D | Discontinued by firm | 2026-10-05 | |
| excluded package | package | 84165-109 | 84165-109-40 | D | Discontinued by firm | 2026-10-05 | |
| excluded package | package | 84165-109 | 84165-109-48 | D | Discontinued by firm | 2026-10-05 | |
| excluded package | package | 84165-109 | 84165-109-60 | D | Discontinued by firm | 2026-10-05 | |
| excluded package | package | 84165-109 | 84165-109-72 | D | Discontinued by firm | 2026-10-05 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Dataset | Scope | Package NDC |
|---|---|---|
| excluded product | product | |
| excluded package | package | 84165-109-40 |
| excluded package | package | 84165-109-10 |
| excluded package | package | 84165-109-60 |
| excluded package | package | 84165-109-20 |
| excluded package | package | 84165-109-01 |
| excluded package | package | 84165-109-18 |
| excluded package | package | 84165-109-06 |
| excluded package | package | 84165-109-72 |
| excluded package | package | 84165-109-32 |
| excluded package | package | 84165-109-12 |
| excluded package | package | 84165-109-04 |
| excluded package | package | 84165-109-30 |
| excluded package | package | 84165-109-48 |
| excluded package | package | 84165-109-08 |
| excluded package | package | 84165-109-36 |
| excluded package | package | 84165-109-13 |
| excluded package | package | 84165-109-24 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.